Thus, the present findings of the potent suppressive effects of C6 on the HMGB1-RAGE-ERK1/2 signaling pathway may give us clues for a new way to further develop novel and effective anti-cancer drugs and therapeutic strategies against various cancers, although further studies with additional cancer cell types are needed to confirm these results. Here, MAPK3 is linked to cancer.